Thomas CM - Search Results

1

Earlier diagnosis and serum human chorionic gonadotropin regression in complete hydatidiform moles.

Kerkmeijer LG, Massuger LF, Ten Kate-Booij MJ, Sweep FC, Thomas CM. Kerkmeijer LG, et al. Among authors: thomas cm. Obstet Gynecol. 2009 Feb;113(2 Pt 1):326-31. doi: 10.1097/AOG.0b013e3181945a4f. Obstet Gynecol. 2009. PMID: 19155902

2

Serum Human Chorionic Gonadotropin Normogram for the Detection of Gestational Trophoblastic Neoplasia.

Eysbouts Y, Brouwer R, Ottevanger P, Massuger L, Sweep F, Thomas C, van Herwaarden A. Eysbouts Y, et al. Int J Gynecol Cancer. 2017 Jun;27(5):1035-1041. doi: 10.1097/IGC.0000000000000966. Int J Gynecol Cancer. 2017. PMID: 28498241

3

Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease.

van Trommel NE, Massuger LF, Schijf CP, ten Kate-Booij MJ, Sweep FC, Thomas CM. van Trommel NE, et al. Among authors: thomas cm. J Clin Oncol. 2006 Jan 1;24(1):52-8. doi: 10.1200/JCO.2005.03.3043. J Clin Oncol. 2006. PMID: 16382113

4

Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease.

Duc HN, van Trommel NE, Sweep FC, Massuger LF, Thomas CM. Duc HN, et al. Among authors: thomas cm. Int J Biol Markers. 2006 Jan-Mar;21(1):45-9. Int J Biol Markers. 2006. PMID: 16711513

5

Human chorionic gonadotropin (hCG) regression normograms for patients with high-risk gestational trophoblastic neoplasia treated with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy.

Lybol C, Westerdijk K, Sweep FCGJ, Ottevanger PB, Massuger LFAG, Thomas CMG. Lybol C, et al. Ann Oncol. 2012 Nov;23(11):2903-2906. doi: 10.1093/annonc/mds199. Epub 2012 Jun 22. Ann Oncol. 2012. PMID: 22730100 Free article.

6

Fatal cases of gestational trophoblastic neoplasia over four decades in the Netherlands: a retrospective cohort study.

Lybol C, Centen DW, Thomas CM, ten Kate-Booij MJ, Verheijen RH, Sweep FC, Ottevanger PB, Massuger LF. Lybol C, et al. Among authors: thomas cm. BJOG. 2012 Nov;119(12):1465-72. doi: 10.1111/j.1471-0528.2012.03480.x. Epub 2012 Aug 24. BJOG. 2012. PMID: 22925191

7

Comparison of human chorionic gonadotropin +beta and invasive trophoblast antigen disappearance rates in serum after evacuation of molar pregnancy.

Van Trommel NE, Sweep FC, Ross HA, Massuger LF, Thomas CM. Van Trommel NE, et al. Among authors: thomas cm. Int J Mol Med. 2006 Oct;18(4):705-11. Int J Mol Med. 2006. PMID: 16964426

8

Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.

Kerkmeijer LG, Wielsma S, Massuger LF, Sweep FC, Thomas CM. Kerkmeijer LG, et al. Among authors: thomas cm. Gynecol Oncol. 2007 Jul;106(1):142-6. doi: 10.1016/j.ygyno.2007.03.010. Epub 2007 Apr 26. Gynecol Oncol. 2007. PMID: 17462723

9

Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.

Thomas CM, Kerkmeijer LG, Ariaens HJ, van der Steen RC, Massuger LF, Sweep FC. Thomas CM, et al. Gynecol Oncol. 2010 Apr;117(1):47-52. doi: 10.1016/j.ygyno.2010.01.008. Epub 2010 Feb 8. Gynecol Oncol. 2010. PMID: 20116088

10

Increase in the incidence of gestational trophoblastic disease in The Netherlands.

Lybol C, Thomas CM, Bulten J, van Dijck JA, Sweep FC, Massuger LF. Lybol C, et al. Among authors: thomas cm. Gynecol Oncol. 2011 May 1;121(2):334-8. doi: 10.1016/j.ygyno.2011.01.002. Epub 2011 Jan 17. Gynecol Oncol. 2011. PMID: 21247618

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

814 results

Search Page

Filters